Stone Ridge Asset Management LLC purchased a new position in Humana Inc (NYSE:HUM) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 12,451 shares of the insurance provider’s stock, valued at approximately $3,089,000.
Several other institutional investors and hedge funds also recently modified their holdings of HUM. Nationwide Fund Advisors boosted its position in shares of Humana by 0.4% in the 3rd quarter. Nationwide Fund Advisors now owns 170,587 shares of the insurance provider’s stock worth $41,560,000 after purchasing an additional 758 shares in the last quarter. Raymond James Financial Services Advisors Inc. boosted its position in shares of Humana by 68.0% in the 3rd quarter. Raymond James Financial Services Advisors Inc. now owns 4,724 shares of the insurance provider’s stock worth $1,151,000 after purchasing an additional 1,912 shares in the last quarter. Gamco Investors INC. ET AL boosted its position in shares of Humana by 71.5% in the 3rd quarter. Gamco Investors INC. ET AL now owns 8,875 shares of the insurance provider’s stock worth $2,162,000 after purchasing an additional 3,700 shares in the last quarter. Principal Financial Group Inc. boosted its position in shares of Humana by 10.5% in the 3rd quarter. Principal Financial Group Inc. now owns 386,776 shares of the insurance provider’s stock worth $94,230,000 after purchasing an additional 36,899 shares in the last quarter. Finally, HL Financial Services LLC boosted its position in shares of Humana by 37.8% in the 3rd quarter. HL Financial Services LLC now owns 10,975 shares of the insurance provider’s stock worth $2,674,000 after purchasing an additional 3,012 shares in the last quarter. 97.85% of the stock is currently owned by hedge funds and other institutional investors.
In other Humana news, SVP Brian P. Leclaire sold 1,679 shares of the business’s stock in a transaction on Thursday, December 21st. The shares were sold at an average price of $245.97, for a total transaction of $412,983.63. Following the completion of the sale, the senior vice president now directly owns 9,888 shares in the company, valued at approximately $2,432,151.36. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, VP Timothy S. Huval sold 1,382 shares of the business’s stock in a transaction on Tuesday, December 19th. The shares were sold at an average price of $246.04, for a total transaction of $340,027.28. Following the sale, the vice president now owns 11,557 shares of the company’s stock, valued at $2,843,484.28. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 40,579 shares of company stock valued at $10,842,942. Company insiders own 0.60% of the company’s stock.
Humana (NYSE:HUM) last announced its earnings results on Wednesday, February 7th. The insurance provider reported $2.06 earnings per share for the quarter, beating analysts’ consensus estimates of $2.00 by $0.06. The business had revenue of $13.19 billion during the quarter, compared to analyst estimates of $13.14 billion. Humana had a net margin of 4.55% and a return on equity of 16.13%. The company’s quarterly revenue was up 2.4% compared to the same quarter last year. During the same period in the previous year, the business earned $2.34 EPS. equities research analysts predict that Humana Inc will post 13.81 earnings per share for the current year.
Humana announced that its Board of Directors has initiated a share repurchase plan on Thursday, December 14th that allows the company to buyback $3.00 billion in shares. This buyback authorization allows the insurance provider to reacquire shares of its stock through open market purchases. Shares buyback plans are generally an indication that the company’s board of directors believes its stock is undervalued.
The business also recently announced a quarterly dividend, which will be paid on Friday, April 27th. Shareholders of record on Friday, March 30th will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Wednesday, March 28th. This is a positive change from Humana’s previous quarterly dividend of $0.40. This represents a $2.00 dividend on an annualized basis and a yield of 0.73%. Humana’s payout ratio is currently 9.59%.
A number of brokerages have recently commented on HUM. Deutsche Bank boosted their price target on Humana from $259.00 to $270.00 and gave the stock a “hold” rating in a research report on Friday, February 9th. Cantor Fitzgerald reissued a “hold” rating and issued a $250.00 price target on shares of Humana in a research report on Wednesday, February 7th. Credit Suisse Group raised Humana from a “neutral” rating to an “outperform” rating and dropped their price target for the stock from $264.90 to $246.00 in a research report on Thursday, February 8th. JPMorgan Chase & Co. boosted their price target on Humana from $253.00 to $271.00 and gave the stock a “neutral” rating in a research report on Monday, February 12th. Finally, Goldman Sachs Group began coverage on Humana in a research report on Wednesday, January 3rd. They issued a “buy” rating and a $305.00 price target on the stock. Seven analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. Humana has an average rating of “Buy” and an average price target of $270.47.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.